Morphosys Ag (MOR) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Morphosys Ag  (NASDAQ: MOR)


Morphosys Ag's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Morphosys Ag's ROI in the fourth quarter of 2023?
Morphosys Ag recorded a cumulative net loss of $-213 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -10.77%.

Within the Healthcare sector 285 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 3411.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -16.31 % -13.93 % -11.65 % -9.45 % -7.33 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,973 1,973 1,973 1,973 2,358
Return On Investment (TTM) -10.77 % -8.17 % -7.81 % -7.48 % -7.18 %
MOR's Overall Ranking # 3411 # 0 # 0 # 0 # 3743
Seq. Investment Change TTM -4.64 % -4.44 % -4.25 % -4.08 % -1.94 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -213 -169 -169 -169 -169

MOR Company Profile >> Back to MOR Roi Comparisons >> See Annual MOR Return On Investment



Return On Investment MOR's Ranking
Within: No.
Industry # 98
Sector # 286
Overall # 3411

Return On Investment Statistics
High Average Low
7.06 %
-11.44 %
-23.69 %
(Dec 31 2020)   (Dec 31 2019)







Financial Statements
Morphosys Ag's IV. Quarter Investments $ 1,973 Millions MOR's Balance sheet
Morphosys Ag's IV. Quarter Income $ -213 Millions Quarterly MOR's Income Statement
MOR's Income by Division See MOR's Income by Division


MOR Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 1,973 2,358 2,544 1,553 487
Y / Y Investment Growth -16.31 % -7.33 % 63.87 % 218.78 % -11.76 %
Net Income in Millions -213 -169 -576 110 -115
Y / Y Net Income Growth - - - - -
Annual Return On Investment -10.77 % -7.18 % -22.65 % 7.06 % -23.69 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MOR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MOR's Competitors
Subscribers only: Roi for Morphosys Ag's Suppliers
Subscribers only: Return On Investment for MOR's Customers

Other Ratios
MOR's Roa MOR's Inventory Turnover Ratio MOR's Growth Rates MOR's Dividend Statistics
MOR's Profitability Ratios MOR's Asset Turnover Ratio MOR's Dividend Growth
MOR's Roe MOR's Valuation Ratios MOR's Financial Strength Ratios MOR's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-02T20:36:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.